Stephen S. Galliker, Director at RXI PHARMACEUTICALS CORP (RXII), sold 15,000 shares at $5.54 ($83K) on 2010-03-26, disclosed to the SEC on 2010-03-30.
Open-market sale of $83k RXII by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |